Items where Division is "Current Faculties > Faculty of Medicine > NIHR Southampton Clinical Research Facility" and Year is 2024
 | Up a level |
Number of items: 9.
An open label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infants - Anna Calvert, Nick Andrews and Sheula Barlow
Type: Article
| 2024
Non-pharmaceutical interventions for COVID-19 transiently reduced pneumococcal and Haemophilus influenzae carriage in a cross-sectional paediatric cohort in Southampton, UK - David W. Cleary, James Campling, Maria Lahuerta, Kyla Hayford, Jo Southern, Bradford D. Gessner, Stephanie W. Lo, Stephen D. Bentley, Saul N. Faust and Stuart C. Clarke
Type: Article
| 2024
Autogenic splenic implantation versus splenectomy in patients undergoing distal pancreatectomy for benign or low-grade malignant lesions of the distal pancreas: study protocol for a multicentre, open-label, randomized controlled trial (RESTORE) - Mohammed Abu Hilal, Christoph Kuemmerli, Jasper P. Sijberden, Alma Moekotte, Giuseppe Zimmitti, Adnan Alseidi, Horacio J. Asbun, Ravi Marudanayagam, Morgan Bonds, Filipe Kunzler, Robert Sutcliffe, Efrem Eren, John N. Primrose and Anthony P. Williams
Type: Article
| 2024
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - Peter W. Horby, Leon Peto, Natalie Staplin, Mark Campbell, Guilherme Pessoa-Amorim and Marion Mafham
Type: Article
| 2024
Oral valganciclovir initiated beyond one month of age as treatment of sensorineural hearing loss caused by congenital cytomegalovirus infection: a randomized clinical trial - David W. Kimberlin, Inmaculada Aban and Kalyani Peri
Type: Article
| 2024
| Item availability restricted.
Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI) - Marianne Leruez-Ville, Christos Chatzakis and Daniele Lilleri
Type: Review
| 2024
Vaccination against COVID-19: risks and benefits in children - Alasdair P.S. Munro, Christine E. Jones and Saul N. Faust
Type: Article
| 2024
Safety and immunogenicity of a ChAd155-vectored respiratory syncytial virus vaccine in infants 6–7 months of age: a phase 1/2 randomized trial - Xavier Sáez-llorens, Ximena Norero, Marisa Márcia Mussi-pinhata, Kathia Luciani, Ignacio Salamanca De La Cueva, Javier Díez-domingo, Eduardo Lopez-medina, Cristina Epalza, Jerzy Brzostek, Henryk Szymański, François D. Boucher, Benhur S. Cetin, Tirza De Leon, Ener Cagri Dinleyici, Miguel Ángel Marín Gabriel, Tolga Ince, Mercedes Macias-parra, Joanne M. Langley, Federico Martinón-torres, Mika Rämet, Ernest Kuchar, Jorge Pinto, Thanyawee Puthanakit, Fernando Baquero-artigao, Guido Castelli Gattinara, Jose Manuel Merino Arribas, Jose Tomas Ramos Amador, Leszek Szenborn, Bruce Tapiero, Evan J. Anderson, James D. Campbell, Saul N. Faust, Vanja Nikic, Yingjun Zhou, Wenji Pu, Damien Friel, Ilse Dieussaert, Antonio Gonzalez Lopez, Roderick Mcphee, Sonia K. Stoszek and Nicolas Vanhoutte
Type: Article
| 2024